These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36759749)

  • 1. Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates.
    Starr MC; Schmicker RH; Halloran BA; Heagerty P; Brophy P; Goldstein SL; Juul SE; Hingorani S; Askenazi DJ;
    Pediatr Res; 2023 Aug; 94(2):676-682. PubMed ID: 36759749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Kidney Injury and Bronchopulmonary Dysplasia in Premature Neonates Born Less than 32 Weeks' Gestation.
    Starr MC; Boohaker L; Eldredge LC; Menon S; Griffin R; Mayock DE; Li L; Askenazi D; Hingorani S;
    Am J Perinatol; 2020 Feb; 37(3):341-348. PubMed ID: 31777046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
    J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid status in the first 10 days of life and death/bronchopulmonary dysplasia among preterm infants.
    Soullane S; Patel S; Claveau M; Wazneh L; Sant'Anna G; Beltempo M
    Pediatr Res; 2021 Aug; 90(2):353-358. PubMed ID: 33824447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury is associated with bronchopulmonary dysplasia/mortality in premature infants.
    Askenazi D; Patil NR; Ambalavanan N; Balena-Borneman J; Lozano DJ; Ramani M; Collins M; Griffin RL
    Pediatr Nephrol; 2015 Sep; 30(9):1511-8. PubMed ID: 25808019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates: A Secondary Analysis of the PENUT Randomized Clinical Trial.
    Starr MC; Griffin RL; Harer MW; Soranno DE; Gist KM; Segar JL; Menon S; Gordon L; Askenazi DJ; Selewski DT
    JAMA Netw Open; 2023 Aug; 6(8):e2328182. PubMed ID: 37561461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.
    Rayjada N; Barton L; Chan LS; Plasencia S; Biniwale M; Bui KC
    Neonatology; 2012; 102(4):287-92. PubMed ID: 22922736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels.
    Abdi HH; Backes CH; Ball MK; Talavera-Barber MM; Klebanoff MA; Jadcherla SR; Mohamed TH; Slaughter JL
    J Perinatol; 2021 Apr; 41(4):749-755. PubMed ID: 33664466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
    Yang T; Shen Q; Wang S; Dong T; Liang L; Xu F; He Y; Li C; Luo F; Liang J; Tang C; Yang J
    BMC Pediatr; 2022 Apr; 22(1):200. PubMed ID: 35413820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a Bundle Approach to Prevent Bronchopulmonary Dysplasia in Very Premature Infants.
    Ratliff-Crain D; Wallingford B; Jorgenson L
    Adv Neonatal Care; 2022 Aug; 22(4):300-308. PubMed ID: 34334675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
    Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
    Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
    Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.